Skip to main content

Table 2 Laboratory results of the patient

From: Patient with multiple acyl-CoA dehydrogenase deficiency disease and ETFDH mutations benefits from riboflavin therapy: a case report

Tests

Results

Reference index

Units

Albumin

38

35–48

g/L

Alanine transferase

37

17–63

U/L

Alkaline phosphatase

46

38–126

U/L

Bilirubin

12

7–31

umol/L

Calcium

2.28

2.15–2.58

mmol/L

Carnitine, serum

 Carnitine, total

47

34–78

nmol/ml

 Carnitine, free (FC)

28

25–54

nmol/ml

 Acylcarnitine (AC)

19

5–30

nmol/ml

 AC/FC Ratio

0.7

0.1–0.8

 

Creatinine

66

60–105

umol/L

Creatinine kinase

492

50–250

U/L

Glucose, fasting

6.0

3.0–6.0

mmol/L

Glycated Hemoglobin

6.4

%

Lipid Panel

 Cholesterol

5.2

 

mmol/L

 HDL-C

1.4

 

mmol/L

 LDL-C

3.4

 

mmol/L

 Triglycerides

0.9

 

mmol/L

Myoglobin

294

16–96

ug/L

Riboflavin, serum

6

1–19

ug/L

Thyroxine, free

13

8–21

pmol/L

TSH

2.69

0.34–5.60

mIU/L

25-OH vitamin D

24

> 20

ug/L

  1. Numbers out of reference index are in bold